KPRX: Kiora Pharmaceuticals, Inc. Stock

by  •  • Comments Off on KPRX: Kiora Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 14.62
Enterprise Value ($M) -16.65
Book Value ($M) 34.90
Book Value / Share 1.33
Price / Book 0.42
NCAV ($M) 25.95
NCAV / Share 0.99
Price / NCAV 0.56

Profitability (mra)
Return on Invested Capital (ROIC) 0.08
Return on Assets (ROA) 0.17
Return on Equity (ROE) 0.28

Liquidity (mrq)
Quick Ratio 21.02
Current Ratio 21.02

Balance Sheet (mrq) ($M)
Current Assets 33.48
Assets 42.44
Liabilities 7.54
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -8.69
Net Income -12.51
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -9.56
Cash from Investing 0.00
Cash from Financing 5.97

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-13 13G/A Lind Global Fund II LP 9.90 144.57
02-09 13G Stonepine Capital Management, LLC 9.99
02-07 13G Hirschman Orin 9.90
02-06 13G/A Intracoastal Capital, Llc 1.50 -32.22

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-03-25 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K
2023-11-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-17 41,300 144,679 28.55
2024-05-16 197,378 86,378 228.50
2024-05-15 22,988 47,072 48.84
2024-05-14 37,263 110,400 33.75
2024-05-13 22,267 63,926 34.83

(click for more detail)

Similar Companies
JSPR – Jasper Therapeutics, Inc. KA – Kineta, Inc.
KALA – KALA BIO, Inc. KRRO – Korro Bio, Inc.
KTRA – Kintara Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io